43 related articles for article (PubMed ID: 28732748)
1. No evidence for interactions of dimethylfumarate (DMF) and its main metabolite monomethylfumarate (MMF) with human cytochrome P450 (CYP) enzymes and the P-glycoprotein (P-gp) drug transporter.
Aubets J; Jansat JM; Salva M; Birks VM; Cole RJ; Lewis J; Pitcher A; Hall M
Pharmacol Res Perspect; 2019 Dec; 7(6):e00540. PubMed ID: 31832203
[TBL] [Abstract][Full Text] [Related]
2. Real-life experience with dimethylfumarate in palmoplantar psoriasis: A multicentre retrospective Italian study.
Giacomo C; Emanuele T; Martina B; Eugenio C; Federico D; Viviana L; Maria PL; Ruslana GS; Thais FM; Marco M; Elena C; Annamaria O; Aurora P; Francesca P
Australas J Dermatol; 2024 Jun; 65(4):e92-e96. PubMed ID: 38268135
[TBL] [Abstract][Full Text] [Related]
3. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris.
Chamian F; Lowes MA; Lin SL; Lee E; Kikuchi T; Gilleaudeau P; Sullivan-Whalen M; Cardinale I; Khatcherian A; Novitskaya I; Wittkowski KM; Krueger JG
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2075-80. PubMed ID: 15671179
[TBL] [Abstract][Full Text] [Related]
4. ErbB4 affects Th1/Th17 cell differentiation and promotes psoriasis progression.
Tang R; Cui H; Dou R; Tao L; Tan L; Guo T; Luo D
Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(12):1-5. PubMed ID: 38063127
[TBL] [Abstract][Full Text] [Related]
5. Single-cell sequencing analysis and multiple machine-learning models revealed the cellular crosstalk of dendritic cells and identified FABP5 and KLRB1 as novel biomarkers for psoriasis.
Ma Z; An P; Hao S; Huang Z; Yin A; Li Y; Tian J
Front Immunol; 2024; 15():1374763. PubMed ID: 38596682
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 20 regulates dendritic cell migration and expression of co-stimulatory molecules.
Bech R; Jalilian B; Agger R; Iversen L; Erlandsen M; Otkjaer K; Johansen C; Paludan SR; Rosenberg CA; Kragballe K; Vorup-Jensen T
Mol Cell Ther; 2016; 4():1. PubMed ID: 26819710
[TBL] [Abstract][Full Text] [Related]
7. Fumaric Acid and its esters: an emerging treatment for multiple sclerosis.
Moharregh-Khiabani D; Linker RA; Gold R; Stangel M
Curr Neuropharmacol; 2009 Mar; 7(1):60-4. PubMed ID: 19721818
[TBL] [Abstract][Full Text] [Related]
8. Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies.
Ricci AA; Dapavo P; Mastorino L; Roccuzzo G; Wolff S; Ribero S; Cassoni P; Senetta R; Quaglino P
J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959285
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent manner.
Hoffmann JHO; Schaekel K; Hartl D; Enk AH; Hadaschik EN
Br J Dermatol; 2018 Jan; 178(1):207-214. PubMed ID: 28733990
[TBL] [Abstract][Full Text] [Related]
10. Causal role of immune cells in psoriasis: a Mendelian randomization analysis.
Wang A; Zhang J
Front Immunol; 2024; 15():1326717. PubMed ID: 38558803
[TBL] [Abstract][Full Text] [Related]
11. Dendritic Cells and Macrophages in the Pathogenesis of Psoriasis.
Kamata M; Tada Y
Front Immunol; 2022; 13():941071. PubMed ID: 35837394
[TBL] [Abstract][Full Text] [Related]
12. Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo).
Ahmad F; Döbel T; Schmitz M; Schäkel K
Front Immunol; 2019; 10():948. PubMed ID: 31191513
[TBL] [Abstract][Full Text] [Related]
13. Psoriasis Pathogenesis and Treatment.
Rendon A; Schäkel K
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909615
[TBL] [Abstract][Full Text] [Related]
14. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
15. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
[TBL] [Abstract][Full Text] [Related]
16. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
[TBL] [Abstract][Full Text] [Related]
17. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
[TBL] [Abstract][Full Text] [Related]
18. Dimethylfumarate for psoriasis: more than a dietary curiosity.
Mrowietz U; Asadullah K
Trends Mol Med; 2005 Jan; 11(1):43-8. PubMed ID: 15649822
[TBL] [Abstract][Full Text] [Related]
19. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
Döbel T; Schäkel K
J Dtsch Dermatol Ges; 2014 Oct; 12(10):874-80. PubMed ID: 25262889
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
